Access the full text.
Sign up today, get DeepDyve free for 14 days.
H. Müllerová, A. Agustí, S. Erqou, D. Mapel (2013)
Cardiovascular comorbidity in COPD: systematic literature review.Chest, 144 4
E. Hnizdo, H. Glindmeyer, E. Petsonk, P. Enright, A. Buist (2006)
Case Definitions for Chronic Obstructive Pulmonary DiseaseCOPD: Journal of Chronic Obstructive Pulmonary Disease, 3
Balwinder Singh, Amandeep Singh, Adil Ahmed, G. Wilson, B. Pickering, V. Herasevich, O. Gajic, Guangxi Li (2012)
Derivation and validation of automated electronic search strategies to extract Charlson comorbidities from electronic medical records.Mayo Clinic proceedings, 87 9
H. Ortapamuk, S. Naldoken (2006)
Brain perfusion abnormalities in chronic obstructive pulmonary disease: comparison with cognitive impairmentAnnals of Nuclear Medicine, 20
J. Torre (1999)
Critical threshold cerebral hypoperfusion causes Alzheimer’s disease?Acta Neuropathologica, 98
R. Petersen, R. Roberts, D. Knopman, Y. Geda, R. Cha, V. Pankratz, B. Boeve, E. Tangalos, R. Ivnik, W. Rocca (2010)
Prevalence of mild cognitive impairment is higher in menNeurology, 75
P. Barnes (2000)
Chronic obstructive pulmonary disease.The New England journal of medicine, 343 4
V. Keatings, P. Collins, Denise Scott, P. Barnes (1996)
Differences in interleukin-8 and tumor necrosis factor-alpha in induced sputum from patients with chronic obstructive pulmonary disease or asthma.American journal of respiratory and critical care medicine, 153 2
D. Stuss, I. Peterkin, D. Guzman, C. Guzmán, A. Troyer (1997)
Chronic obstructive pulmonary disease: effects of hypoxia on neurological and neuropsychological measures.Journal of clinical and experimental neuropsychology, 19 4
A. Hill, D. Bayley, R. Stockley (1999)
The interrelationship of sputum inflammatory markers in patients with chronic bronchitis.American journal of respiratory and critical care medicine, 160 3
L. Melton (1996)
History of the Rochester Epidemiology Project.Mayo Clinic proceedings, 71 3
A. Beck, R. Steer, R. Ball, W. Ranieri (1996)
Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients.Journal of personality assessment, 67 3
R. Roberts, Y. Geda, D. Knopman, R. Cha, V. Pankratz, B. Boeve, R. Ivnik, E. Tangalos, R. Petersen, W. Rocca (2008)
The Mayo Clinic Study of Aging: Design and Sampling, Participation, Baseline Measures and Sample CharacteristicsNeuroepidemiology, 30
K. Yaffe, K. Lindquist, B. Penninx, E. Simonsick, M. Pahor, S. Kritchevsky, L. Launer, L. Kuller, S. Rubin, T. Harris (2003)
Inflammatory markers and cognition in well-functioning African-American and white eldersNeurology, 61
I. Grant, R. Heaton, A. Mcsweeny, K. Adams, R. Timms, R. Timms (1982)
Neuropsychologic findings in hypoxemic chronic obstructive pulmonary disease.Archives of internal medicine, 142 8
R. Roberts, Y. Geda, D. Knopman, R. Cha, V. Pankratz, B. Boeve, E. Tangalos, R. Ivnik, M. Mielke, R. Petersen (2013)
Cardiac disease associated with increased risk of nonamnestic cognitive impairment: stronger effect on women.JAMA neurology, 70 3
J. Sauver, B. Grossardt, C. Leibson, B. Yawn, B. Yawn, L. Melton, W. Rocca (2012)
Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project.Mayo Clinic proceedings, 87 2
J. Vestbo, S. Hurd, A. Agustí, P. Jones, Claus Vogelmeier, A. Anzueto, P. Barnes, L. Fabbri, F. Martinez, M. Nishimura, R. Stockley, D. Sin, R. Rodríguez-Roisín (2007)
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.American journal of respiratory and critical care medicine, 187 4
S. Fahn, R. Elton, Updrs (2001)
Committee. Unified Parkinson’s Disease Rating Scale., 49
Balwinder Singh, Balwinder Singh, A. Parsaik, M. Mielke, R. Roberts, P. Scanlon, Y. Geda, V. Pankratz, T. Christianson, B. Yawn, R. Petersen (2013)
Chronic obstructive pulmonary disease and association with mild cognitive impairment: the Mayo Clinic Study of Aging.Mayo Clinic proceedings, 88 11
Minna Rusanen, T. Ngandu, T. Laatikainen, J. Tuomilehto, H. Soininen, M. Kivipelto (2013)
Chronic obstructive pulmonary disease and asthma and the risk of mild cognitive impairment and dementia: a population based CAIDE study.Current Alzheimer research, 10 5
S. Villeneuve, V. Pepin, S. Rahayel, J. Bertrand, Myriam Lorimier, Amanda Rizk, C. Desjardins, S. Parenteau, François Beaucage, S. Joncas, O. Monchi, J. Gagnon (2012)
Mild cognitive impairment in moderate to severe COPD: a preliminary study.Chest, 142 6
L. Schou, B. Østergaard, L. Rasmussen, S. Rydahl-Hansen, K. Phanareth (2012)
Cognitive dysfunction in patients with chronic obstructive pulmonary disease--a systematic review.Respiratory medicine, 106 8
E. Kokmen, Glenn Smith, R. Petersen, E. Tangalos, R. Ivnik (1991)
The short test of mental status. Correlations with standardized psychometric testing.Archives of neurology, 48 7
M. Wysocki, Xiaodong Luo, J. Schmeidler, K. Dahlman, G. Lesser, H. Grossman, V. Haroutunian, M. Beeri (2012)
Hypertension is associated with cognitive decline in elderly people at high risk for dementia.The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 20 2
Valentin Centurion, F. Huang, E. Naureckas, Carlos Jr., Jeff Charbeneau, M. Joo, V. Press, J. Krishnan (2012)
Confirmatory spirometry for adults hospitalized with a diagnosis of asthma or chronic obstructive pulmonary disease exacerbationBMC Pulmonary Medicine, 12
E. Ford, J. Croft, D. Mannino, A. Wheaton, Xingyou Zhang, W. Giles (2013)
COPD Surveillance—United States, 1999-2011Chest, 144
J. Dodd, S. Getov, P. Jones (2010)
Cognitive function in COPDEuropean Respiratory Journal, 35
R. Roberts, Y. Geda, D. Knopman, B. Boeve, T. Christianson, V. Pankratz, I. Kullo, E. Tangalos, R. Ivnik, R. Petersen (2009)
Association of C-reactive protein with mild cognitive impairmentAlzheimer's & Dementia, 5
J. Morris (1993)
The Clinical Dementia Rating (CDR)Neurology, 43
Anas Alsara, D. Warner, Guangxi Li, V. Herasevich, O. Gajic, D. Kor (2011)
Derivation and validation of automated electronic search strategies to identify pertinent risk factors for postoperative acute lung injury.Mayo Clinic proceedings, 86 5
S. Fahn (1987)
Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale, 2
R. Incalzi, A. Gemma, C. Marra, R. Muzzolon, O. Capparella, P. Carbonin (1993)
Chronic obstructive pulmonary disease. An original model of cognitive decline.The American review of respiratory disease, 148 2
C. Cooke, M. Joo, Stephen Anderson, Todd Lee, E. Udris, Eric Johnson, D. Au (2011)
The validity of using ICD-9 codes and pharmacy records to identify patients with chronic obstructive pulmonary diseaseBMC Health Services Research, 11
S. Fahn, R. Elton, C. Marsden, D. Calne, M. Goldstein (1986)
Recent Developments in Parkinson's Disease
Jing Li, Yun Huang, G. Fei (2012)
The Evaluation of Cognitive Impairment and Relevant Factors in Patients with Chronic Obstructive Pulmonary DiseaseRespiration, 85
R. Ivnik, J. Malec, Glenn Smith, E. Tangalos, R. Petersen, E. Kokmen, L. Kurland (1992)
Mayo's older americans normative studies: WAIS-R norms for ages 56 to 97Clinical Neuropsychologist, 6
E. Schrijvers, P. Koudstaal, A. Hofman, M. Breteler (2011)
Plasma clusterin and the risk of Alzheimer disease.JAMA, 305 13
M. Bednarek, Janusz Maciejewski, M. Woźniak, P. Kuca, J. Zieliński (2008)
Prevalence, severity and underdiagnosis of COPD in the primary care settingThorax, 63
R. Roberts, Y. Geda, D. Knopman, R. Cha, B. Boeve, R. Ivnik, V. Pankratz, E. Tangalos, R. Petersen (2010)
Metabolic Syndrome, Inflammation, and Nonamnestic Mild Cognitive Impairment in Older Persons: A Population-based StudyAlzheimer Disease & Associated Disorders, 24
R. Incalzi, C. Marra, A. Giordano, M. Calcagni, A. Cappa, S. Basso, G. Pagliari, L. Fuso (2003)
Cognitive impairment in chronic obstructive pulmonary diseaseJournal of Neurology, 250
S. Fahn (1987)
Unified Parkinson's Disease Rating Scale, 2
E. Ettorre, E. Cerra, B. Marigliano, M. Vigliotta, A. Vulcano, C. Fossati, G. Benedetto, A. Servello, P. Andreozzi, V. Marigliano (2012)
Role of cardiovascular risk factors (CRF) in the patients with mild cognitive impairment (MCI).Archives of gerontology and geriatrics, 54 2
R. Roberts, Y. Geda, D. Knopman, R. Cha, V. Pankratz, B. Boeve, E. Tangalos, R. Ivnik, W. Rocca, R. Petersen (2012)
The incidence of MCI differs by subtype and is higher in menNeurology, 78
JC Morris (1993)
The Clinical Dementia Rating (CDR): current version and scoring rules., 43
ImportancePrevious studies suggest cross-sectional associations between a diagnosis of chronic obstructive pulmonary disease (COPD) and mild cognitive impairment (MCI). However, few studies have assessed whether COPD, a potentially modifiable factor, is associated with an increased risk for MCI and whether the relation is specific to the type of MCI. ObjectiveTo investigate whether a diagnosis of COPD and duration of COPD are associated with an increased risk for incident MCI and MCI subtypes (amnestic MCI [A-MCI] and nonamnestic MCI [NA-MCI]). Design, Setting, and ParticipantsA prospective population-based cohort from the Mayo Clinic Study on Aging. We included 1425 cognitively normal individuals aged 70 to 89 years who were randomly selected from Olmsted County, Minnesota, on October 1, 2004, using the medical records linkage system. At baseline and every 15 months thereafter, participants underwent assessment with a nurse interview, neurologic examination, and neuropsychological testing. A diagnosis of COPD was confirmed via medical record review. A baseline diagnosis of COPD and duration of COPD were examined as risk factors for MCI and MCI subtypes using Cox proportional hazards models and adjusting for demographic variables and medical comorbidities, with age as the time scale. ExposureA baseline diagnosis of COPD and duration of COPD. Main Outcomes and MeasuresIncident MCI, A-MCI, and NA-MCI. ResultsOf the 1425 participants with normal cognition at baseline, 370 developed incident MCI. The median duration of follow-up was 5.1 years (interquartile range, 3.8-5.4 years). A diagnosis of COPD significantly increased the risk for NA-MCI by 83% (hazard ratio, 1.83 [95% CI, 1.04-3.23]), but not of any MCI or A-MCI in multivariate analyses. We found a dose-response relationship such that individuals with COPD duration of longer than 5 years at baseline had the greatest risk for any MCI (hazard ratio, 1.58 [95% CI, 1.04-2.40]) and NA-MCI (2.58 [1.32-5.06]). Conclusions and RelevanceA diagnosis of COPD is associated with an increased risk for MCI, particularly NA-MCI. We have found a dose-response relationship between COPD duration and risk for MCI. These findings highlight the importance of COPD as a risk factor for MCI and may provide a substrate for early intervention to prevent or delay the onset and progression of MCI, particularly NA-MCI.
JAMA Neurology – American Medical Association
Published: May 1, 2014
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.